Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: Potential markers for glioma subtype

Cancer Letters

Volumn 171, Issue 1, 2001, Pages 67-77

  Xu, Xueying ^a   Joh, Hong Dong ^a   Pin, Sukhon ^a   Schiller, Noraisha I ^a   Prange, Christa ^b   Burger, Peter C ^a   Schiller, Martin R ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Astrocytoma; Brain tumor; cDNA library; Gene expression; Meningioma; Oligodendroglioma

Indexed keywords

COMPLEMENTARY DNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL CLONE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAY MATTER; HUMAN; HUMAN TISSUE; MENINGIOMA; NORTHERN BLOTTING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SPLICEOSOME; TUMOR DIFFERENTIATION; UNINDEXED SEQUENCE;

ASTROCYTOMA; BLOTTING, NORTHERN; BRAIN NEOPLASMS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GLIOMA; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MOLECULAR WEIGHT; OLIGODENDROGLIOMA; RIBONUCLEOPROTEINS; RNA SPLICING; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE ANALYSIS, DNA; SPLICEOSOMES; SUBTRACTION TECHNIQUE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035964473     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00573-0     Document Type: Article

References (28)

1. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
2. Cloning differentially expressed mRNAs
3. The stage-specific expression of RESP18 in the testes
4. Genes expressed in the mouse pituitary corticotrope AtT-20/D-16v tumor cell line
5. The I.M.A.G.E. Consortium: An integrated molecular analysis of genomes and their expression
6. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
7. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
8. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors
9. BEHAB/brevican: A brain-specific lectican implicated in gliomas and glial cell motility
10. Expression of complement C4 and C9 genes by human astrocytes
11. GFAP in brain tumor diagnosis: Possibilities and limitations
12. Differential expression of insulin-like growth factor II in human meningiomas
13. Expression of epithelial and extracellular matrix protein markers in meningiomas
14. Intermediate filaments in meningiomas
15. Vimentin and glial fibrillary acidic protein in human brain tumors
16. Prostaglandin D synthase (β-trace) in human arachnoid and meningioma cells: Roles as a cell marker or in cerebrospinal fluid, absorption, tumorigenesis, and calcification process
17. A high ratio of insulin-like growth factor II/insulin like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas
18. Expression of translationally controlled tumor protein mRNA in human colon cancer
19. Gene expression of apolipoprotein E in human brain tumors
20. Gene expression of insulin-like growth factor II in human intracranial meningioma
21. Quantification of prostaglandin D synthase in cerebrospinal fluid: A potential marker for brain tumors
22. Heterogeneous ribonucleoprotein A1 is part if an exon-specific splice-silencing complex controlled by oncogenic signaling pathways
23. Cloning and functional characterization of human selenophosphate synthetase, an essential component of selenoprotein synthesis
24. Selenoprotein W accumulates primarily in primate skeletal muscle, heart brain and tongue
25. Selenium is required for normal upregulation of myelin genes in differentiating oligodendrocytes
26. Selenium in the treatment of patients with brain gliomas. A pilot study
27. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures